• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Physiol Lung Cell Mol Physiol . SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol


. 2021 Jan 12.
doi: 10.1152/ajplung.00499.2020. Online ahead of print.
SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport


Reem Abdel Hameid[SUP] 1 [/SUP], Estelle Cormet-Boyaka[SUP] 2 [/SUP], Wolfgang M Kuebler[SUP] 3 [/SUP], Mohammed Uddin[SUP] 4 [/SUP], Bakhrom K Berdiev[SUP] 1 [/SUP]



Affiliations

Abstract

The tropism of SARS-CoV-2, a virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, towards the host cells is determined, at least in part, by the expression and distribution of its cell surface receptor, angiotensin-converting enzyme 2 (ACE2). The virus further exploits the host cellular machinery to gain access into the cells; its spike protein is cleaved by a host cell surface transmembrane serine protease 2 (TMPRSS2) shortly after binding ACE2 followed by its proteolytic activation at a furin cleavage site. The virus primarily targets the epithelium of the respiratory tract which is covered by a tightly regulated airway surface liquid (ASL) layer that serves as a primary defense mechanism against respiratory pathogens. The volume and viscosity of this fluid layer is regulated and maintained by a coordinated function of different transport pathways in the respiratory epithelium. We argue that SARS-CoV-2 may potentially alter evolutionary conserved second-messenger signaling cascades via activation of G-protein coupled receptors (GPCRs) or by directly modulating G protein signaling. Such signaling may in turn adversely modulate transepithelial transport processes, especially those involving cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial Na[SUP]+[/SUP] channel (ENaC), thereby shifting the delicate balance between anion secretion and sodium absorption that controls homeostasis of this fluid layer. As a result, activation of the secretory pathways including CFTR-mediated Cl[SUP]-[/SUP] transport may overwhelm the absorptive pathways such as ENaC-dependent Na[SUP]+[/SUP] uptake and initiate a pathophysiological cascade leading to lung edema, one of the most serious and potentially deadly clinical manifestations of COVID-19.

Keywords: CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2.
 
Back
Top Bottom